Overview

A Study To InvestigateThe Safety, Tolerability And Efficacy Of Nebulised Curosurf® In Preterm Neonates With Respiratory Distress Syndrome (RDS)

Status:
Terminated

Trial end date:
2020-05-05

Target enrollment:

Participant gender:

Summary

The present study will mainly aim at investigating the safety, tolerability and efficacy of different escalating single doses administration of nebulised Curosurf®, in preterm neonates with RDS (Respiratory Distress Syndrome) during nCPAP.

Phase:

Phase 2

Details

Lead Sponsor:

Chiesi Farmaceutici S.p.A.

Treatments:

Poractant alfa
Pulmonary Surfactants